Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies

被引：11
作者：
Sciascia, Savino [1 ,4 ]
Costanzo, Piera [2 ]
Radin, Massimo [1 ,4 ]
Schreiber, Karen [5 ,6 ,7 ]
Pini, Massimo [3 ]
Vaccarino, Antonella [3 ]
Cecchi, Irene [1 ,4 ]
Baldovino, Simone [1 ,4 ]
Roccatello, Dario [1 ,4 ]
机构：
[1] San Giovanni Bosco Hub Hosp, CMID Nephrol & Dialysis Unit, ERK Net, Res Ctr Immunopathol,Coordinating Ctr Network Rar, I-10154 Turin, Italy
[2] San Giovanni Bosco Hub Hosp, Cardiol Unit, Coordinating Ctr Network Rare Dis Piedmont & Aost, I-10154 Turin, Italy
[3] San Giovanni Bosco Hub Hosp, Hematol Unit, Coordinating Ctr Network Rare Dis Piedmont & Aost, I-10154 Turin, Italy
[4] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
[5] Danish Hosp Rheumat Dis, Sonderborg, Denmark
[6] Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark
[7] Guys & St Thomas NHS Fdn Trust, Ctr Haemostasis & Thrombosis, London, England
来源：
LANCET RHEUMATOLOGY | 2021年 / 3卷 / 12期
关键词：
D O I：
10.1016/S2665-9913(21)00320-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E832 / E832
页数：1
相关论文
共 5 条
  • [1] Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
    Boekel, Laura
    Steenhuis, Maurice
    Hooijberg, Femke
    Besten, Yaelle R.
    van Kempen, Zoe L. E.
    Kummer, Laura Y.
    van Dam, Koos P. J.
    Stalman, Eileen W.
    Vogelzang, Erik H.
    Cristianawati, Olvi
    Keijzer, Sofie
    Vidarsson, Gestur
    Voskuyl, Alexandre E.
    Wieske, Luuk
    Eftimov, Filip
    van Vollenhoven, Ronald
    Kuijpers, Taco W.
    van Ham, S. Marieke
    Tas, Sander W.
    Killestein, Joep
    Boers, Maarten
    Nurmohamed, Michael
    Rispens, Theo
    Wolbink, Gertjan
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (11) : E778 - E788
  • [2] Surveillance for Adverse Events After COVID-19 mRNA Vaccination
    Klein, Nicola P.
    Lewis, Ned
    Goddard, Kristin
    Fireman, Bruce
    Zerbo, Ousseny
    Hanson, Kayla E.
    Donahue, James G.
    Kharbanda, Elyse O.
    Naleway, Allison
    Nelson, Jennifer Clark
    Xu, Stan
    Yih, W. Katherine
    Glanz, Jason M.
    Williams, Joshua T. B.
    Hambidge, Simon J.
    Lewin, Bruno J.
    Shimabukuro, Tom T.
    DeStefano, Frank
    Weintraub, Eric S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14): : 1390 - 1399
  • [3] Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
    Medeiros-Ribeiro, Ana C.
    Aikawa, Nadia E.
    Saad, Carla G. S.
    Yuki, Emily F. N.
    Pedrosa, Tatiana
    Fusco, Solange R. G.
    Rojo, Priscila T.
    Pereira, Rosa M. R.
    Shinjo, Samuel K.
    Andrade, Danieli C. O.
    Sampaio-Barros, Percival D.
    Ribeiro, Carolina T.
    Deveza, Giordano B. H.
    Martins, Victor A. O.
    Silva, Clovis A.
    Lopes, Marta H.
    Duarte, Alberto J. S.
    Antonangelo, Leila
    Sabino, Ester C.
    Kallas, Esper G.
    Pasoto, Sandra G.
    Bonfa, Eloisa
    [J]. NATURE MEDICINE, 2021, 27 (10) : 1744 - +
  • [4] Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
    Rotondo, Cinzia
    Cantatore, Francesco Paolo
    Fornaro, Marco
    Colia, Ripalta
    Busto, Giuseppe
    Rella, Valeria
    Sciacca, Stefania
    Lops, Lucia
    Cici, Daniela
    Maruotti, Nicola
    D'Onofrio, Francesca
    Iannone, Florenzo
    Corrado, Addolorata
    [J]. VACCINES, 2021, 9 (07)
  • [5] Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
    Sciascia, Savino
    Radin, Massimo
    Bazzan, Mario
    Montaruli, Barbara
    Cosseddu, Domenico
    Norbiato, Claudio
    Bertero, Maria Tiziana
    Carignola, Renato
    Bacco, Beatrice
    Cassarino, Silvia Gallo
    Roccatello, Dario
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
1